These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38181880)

  • 1. An evaluation of the five rights antibiotic safety before and during COVID-19 at an NHS Foundation Trust in the United Kingdom.
    Elshenawy RA; Umaru N; Aslanpour Z
    J Glob Antimicrob Resist; 2024 Mar; 36():188-189. PubMed ID: 38181880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO AWaRe classification for antibiotic stewardship: tackling antimicrobial resistance - a descriptive study from an English NHS Foundation Trust prior to and during the COVID-19 pandemic.
    Abdelsalam Elshenawy R; Umaru N; Aslanpour Z
    Front Microbiol; 2023; 14():1298858. PubMed ID: 38146447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 on Antibiotic Stewardship, Antimicrobial Resistance, and Prescribing Habits at Two General Hospitals in Abu Dhabi: A Retrospective Analysis.
    Vats K; Singh K; Oommen S
    Cureus; 2024 Sep; 16(9):e69170. PubMed ID: 39398725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prescribing trends in primary care 2014-2022.
    McCloskey AP; Malabar L; McCabe PG; Gitsham A; Jarman I
    Res Social Adm Pharm; 2023 Aug; 19(8):1193-1201. PubMed ID: 37183105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion.
    Bizri AR; El-Fattah AA; Bazaraa HM; Al Ramahi JW; Matar M; Ali RAN; El Masry R; Moussa J; Abbas AJA; Aziz MA
    PLoS One; 2023; 18(7):e0288550. PubMed ID: 37498951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the COVID-19 pandemic on the treatment of common infections in primary care and the change to antibiotic prescribing in England.
    Yang YT; Zhong X; Fahmi A; Watts S; Ashcroft DM; Massey J; Fisher L; MacKenna B; Mehrkar A; Bacon SCJ; Goldacre B; Hand K; van Staa T; Palin V
    Antimicrob Resist Infect Control; 2023 Sep; 12(1):102. PubMed ID: 37717030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study.
    Gulliford MC; Juszczyk D; Prevost AT; Soames J; McDermott L; Sultana K; Wright M; Fox R; Hay AD; Little P; Moore M; Yardley L; Ashworth M; Charlton J
    Health Technol Assess; 2019 Mar; 23(11):1-70. PubMed ID: 30900550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial stewardship in the UK during the COVID-19 pandemic: a population-based cohort study and interrupted time-series analysis.
    Rezel-Potts E; L'Esperance V; Gulliford MC
    Br J Gen Pract; 2021 May; 71(706):e331-e338. PubMed ID: 33690150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the impact of COVID-19 on antibiotic use in Canadian primary care: a matched-cohort study using EMR data.
    Morkem R; Smith G; Knight B; Wong ST; Barber D
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):76. PubMed ID: 38997756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).
    Henley J; Brookes-Howell L; Euden J; Pallmann P; Llewelyn M; Howard P; Powell N; Dark P; Szakmany T; Hellyer TP; Albur M; Hamilton R; Prestwich G; Ogden M; Maboshe W; Sandoe J; Thomas-Jones E; Carrol E; ;
    BMJ Open; 2023 Dec; 13(12):e077117. PubMed ID: 38114276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pattern of antibiotic utilisation among intensive care unit patients hospitalised in a Gauteng (South African) provincial tertiary hospital: Comparing findings before and during COVID-19.
    Spinickum L; Booth Z; Leigh-de Rapper S
    S Afr Med J; 2024 Jul; 114(7):e1812. PubMed ID: 39041519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial stewardship implementation before and during the COVID-19 pandemic in the acute care settings: a systematic review.
    Elshenawy RA; Umaru N; Alharbi AB; Aslanpour Z
    BMC Public Health; 2023 Feb; 23(1):309. PubMed ID: 36765323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic Stewardship Program in a General Hospital in Abu Dhabi, UAE: Preparedness for the COVID-19 Pandemic.
    Vats K; Singh K; Oommen S
    Cureus; 2024 Aug; 16(8):e67270. PubMed ID: 39301392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of antimicrobial stewardship programmes and antibiotic use among children admitted to two hospitals in Sierra Leone: a cross-sectional study.
    Kamara IF; Fofanah BD; Nuwagira I; Kamara KN; Tengbe SM; Abiri O; Kamara RZ; Lakoh S; Farma L; Kamara AK; Hailu B; Dove D; Squire JS; D'Almeida SA; Sheriff B; Mustapha A; Bawa N; Lagesse H; Koroma AT; Kanu JS
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):80. PubMed ID: 39039593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance.
    Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
    Trans R Soc Trop Med Hyg; 2021 Oct; 115(10):1122-1129. PubMed ID: 33772597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Country data on AMR in Russia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Kozlov R; Sidorenko S; Kamble P; Lezhnina M; Galushkin A; Kundu S
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i61-i69. PubMed ID: 36065732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Country data on AMR in Türkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Aktas Z; Unal S; van Hasselt J; Seyhun Y; Keles N
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i51-i60. PubMed ID: 36065733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome.
    Torumkuney D; Kundu S; Vu GV; Nguyen HA; Pham HV; Kamble P; Truong Ha Lan N; Keles N
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i26-i34. PubMed ID: 36065731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial.
    Gulliford MC; Prevost AT; Charlton J; Juszczyk D; Soames J; McDermott L; Sultana K; Wright M; Fox R; Hay AD; Little P; Moore MV; Yardley L; Ashworth M
    BMJ; 2019 Feb; 364():l236. PubMed ID: 30755451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shorter and Longer Antibiotic Durations for Respiratory Infections: To Fight Antimicrobial Resistance-A Retrospective Cross-Sectional Study in a Secondary Care Setting in the UK.
    Abdelsalam Elshenawy R; Umaru N; Aslanpour Z
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.